EVEREST ORGANICS
Back to Balance Sheet
|
EVEREST ORGANICS Last 5 Year Long Term Provisions History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹2.61 Cr | ₹2.32 Cr | ₹1.62 Cr | ₹1.63 Cr | - |
What is the latest Long Term Provisions ratio of EVEREST ORGANICS ?
| Year | Long Term Provisions |
|---|---|
| Mar2026 | ₹2.61 Cr |
| Mar2025 | ₹2.32 Cr |
| Mar2024 | ₹1.62 Cr |
| Mar2023 | ₹1.63 Cr |
| Mar2022 | - |
How is Long Term Provisions of EVEREST ORGANICS Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2026 | ₹2.61 Cr | 12.53 | |
| Mar2025 | ₹2.32 Cr | 43.16 | |
| Mar2024 | ₹1.62 Cr | -0.55 | |
| Mar2023 | ₹1.63 Cr | 0 | |
| Mar2022 | - | - | |
Compare Long Term Provisions of peers of EVEREST ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EVEREST ORGANICS | ₹225.1 Cr | -6.7% | -10% | -42.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,228.0 Cr | -0.8% | 7.3% | 7.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹293,874.0 Cr | -3.3% | 21.8% | 68.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,413.0 Cr | -1.7% | 1.9% | 22.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,604.0 Cr | 0.7% | 12.4% | 12.4% | Stock Analytics | |
| CIPLA | ₹114,720.0 Cr | 0.7% | 6.7% | -9.4% | Stock Analytics | |
EVEREST ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | -6.7% |
-10% |
-42.2% |
| SENSEX | 0.2% |
9.8% |
-2.9% |
You may also like the below Video Courses